10-K Decoder · All companies

Rocket Pharmaceuticals, Inc.

RCKT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$232M−$273M+15.2%
Net income−$223M−$259M+13.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 12, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$51.0M−$52.2M+2.3%
Net income−$49.2M−$50.3M+2.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Rocket Pharmaceuticals's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Rocket Pharmaceuticals profitable in FY2025?
No: net income was −$223M and operating income −$232M in FY2025.
What was Rocket Pharmaceuticals's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 12, 2026.